TIMI Study Group
Michelle O'Donoghue, MD MPH is a Senior Investigator at TIMI Study Group and an Affiliate Physician at Massachusetts General Hospital. Michelle also holds the title of Associate Physician in Cardiovascular Medicine at Brigham and Women's Hospital. Michelle earned their Doctor of Medicine (MD) from Columbia University Vagelos College of Physicians and Surgeons in 2002, and later obtained a Master of Public Health (MPH) from Harvard T.H. Chan School of Public Health in 2009. Michelle completed their Bachelor's Degree in Physiology, General from McGill University in 1998.
TIMI Study Group
Since its inception in 1984, the TIMI Study Group has been an Academic Research Organization dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease. We have led a wide array of trials, from phase I to phase IV, enrolling from less than 30 to more than 26,000 subjects, and with both industry and NIH support. Trials have been conducted in over 50 countries and at more than 5000 separate sites. We investigate a broad array of therapeutic interventions in individuals across the spectrum of cardiovascular disease, ranging from prevention in those with risk factors, to emergent interventions in those with acute manifestations of disease. In addition, we have used our large database of clinical findings, biomarkers, and genotypes to enhance the understanding of cardiovascular disease and its risk factors. By leading large-scale, international, randomized controlled trials of novel therapeutics and performing sophisticated analyses, we have been privileged to help shape the very practice of cardiovascular medicine for over a quarter of a century.